Vodcast Series Putting evidence into practice: Tips for starting and continuing GLP-1 RAs Claim CE Credit Episode 7: Barriers to GLP-1 RAs Claim CE and MOC Credit Selecting the Right Patient at the Right Time Claim CE Credit Practical Pointers to Optimize the Use of GLP-1 RAs Claim CE Credit Chronic Kidney Disease and GLP-1 RAs Cardiovascular Benefits of GLP-1 RAs Claim CE and MOC Credit Demystifying GLP-1s Claim CE and MOC Credit Obesity and GLP-1 RAs Claim CE Credit Guidelines and Articles 2021 Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Hart Association/American Stroke Association | Stroke 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes | Circulation Cardiorenal Protection With the Newer Antidiabetic Agents in Patients With Diabetes and Chronic Kidney Disease: A Scientific Statement From the American Heart Assocation | Circulation References 1 Arnett DK, Blumenthal RS, Albert MA, et al
95% CI, 0.73-1.90) (83)
Progesterone influences sleep quality, sleep disruption can increase cortisol levels, and elevated cortisol may amplify side effects such as nausea or digestive discomfort
Biochem Biophys Res Commun (2015) 458(2):2749
[DOI] [PubMed] [Google Scholar] 178.Parker HE, Adriaenssens A, Rogers G, Richards P, Koepsell H, Reimann F, Gribble FM
These mechanisms are scientifically plausible, but they are not yet established well enough to say that GLP-1 drugs directly age the face independent of weight loss
